PARTNER: randomised, phase II/III trial to evaluate the safety and efficacy of the addition of olaparib to platinum-based neoadjuvant chemotherapy in triple negative and/or germline BRCA mutated breast cancer patients
Abraham, JE Pinilla, K Vallier, AL Grybowicz, L Qian, W Thomas, S Weiss, M Harvey, C Kateb, A Machin, A
Abraham, JE
Pinilla, K
Vallier, AL
Grybowicz, L
Qian, W
Thomas, S
Weiss, M
Harvey, C
Kateb, A
Machin, A
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2020
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Abraham JE, Pinilla K, Vallier AL, Grybowicz L, Qian W, Thomas S, et al. PARTNER: randomised, phase II/III trial to evaluate the safety and efficacy of the addition of olaparib to platinum-based neoadjuvant chemotherapy in triple negative and/or germline BRCA mutated breast cancer patients. Breast Cancer Research and Treatment. 2020;180:585-6